XRCC6 and lung carcinoma: Epigallocatechin-3-gallate (EGCG)-induced apoptosis in lung cancer cells is mediated by decreased Ku70, and EGCG disrupts the interaction between Ku70 and Bax, which leads to an increased Bax expression in lung cancer cells [29].